Target intelligence / Profile preview

Integrin, alpha X pseudogene

Molecular classification: Other (Pseudogene)

Overview

Integrin, alpha X pseudogene refers to a nonfunctional DNA sequence that is similar to the functional ITGAX (integrin alpha X) gene but does not encode a functional protein. Pseudogenes like this arise by gene duplication or retrotransposition processes and typically lack regulatory elements or contain mutations that prevent proper transcription or translation. As a result, these sequences do not have biological activity and are not considered therapeutic targets. Most pseudogenes are regarded as "junk DNA," though a subset may have regulatory RNA roles in rare cases[3][1].

Beyond the preview

Go deeper on Integrin, alpha X pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrin, alpha X pseudogene.

Explore the full profile